AddTweet This Post to Facebook hEmail this
‹‹ Go Back

Bonnie J. Clemence, MSN, RN, CRNI

Harrisburg, Maryland



‹‹ Go Back

Anita Patton, BSN, RN, VA-BC

Miami Valley Hospital, Dayton, Ohio



‹‹ Go Back

Jamie Jenkins, BSN, RN, VA-BC

Miami Valley Hospital, Dayton, Ohio



‹‹ Go Back

Dan Estel, RN, BS

Principal Member, NursePro Plus, LLC, Morgantown, West Virginia



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

Platinum Showcases

Risk Factors Associated with Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with PICCs
New PICC Technology for the Reduction of Catheter Related UEDVTs
Clinical Impacts of the Celerity Tip Confirmation System and BioFlo PICCs

calendar9/9/2014

clock5:00 PM - 6:00 PM

clockRoom: Chesapeake 4-6

Bonnie J. Clemence, MSN, RN, CRNI

Harrisburg, Maryland

Anita Patton, BSN, RN, VA-BC

Miami Valley Hospital, Dayton, Ohio

Jamie Jenkins, BSN, RN, VA-BC

Miami Valley Hospital, Dayton, Ohio

Dan Estel, RN, BS

Principal Member, NursePro Plus, LLC, Morgantown, West Virginia

AngioDynamics’ introduction of BioFlo catheters provides an option for vascular access with anti-thrombotic properties, reducing platelet adhesion and thrombus formation, in the early stages of the coagulation cascade. A permanent, non-eluting polymer is blended into the catheter material rendering a surface that is highly resistant to the accumulation of platelets and thrombus, and remains present for the life of the catheter. The BioFlo PICC was the first permanent anti-thrombotic catheter material to receive clearance from the FDA in 2012. In-vitro models demonstrated on average, 87% less thrombus accumulation on its surface compared to conventional non-coated PICCs (based on platelet count). Join us as Bonnie Clemence, co-author, nurse researcher and vascular access nurse presents her recently published study, which identifies the 28 risk factors associated with catheter-related upper extremity deep vein thrombosis in patients with peripherally inserted central venous catheters. Miami Valley Hospital will present the results of its two year study to determine if the BioFlo PICC with Endexo Technology could provide a lower complication rate. And in closing, NurseProPlus, the first team in the USA to implement Celerity PICC Tip Confirmation System, will discuss tip location accuracy of placement along with BioFlo PICCs and their effect on catheter patency and venous thrombosis.

Learning Objectives:

  • Heighten awareness of innovative catheter technology which reduces catheter-related upper extremity deep vein thrombosis.
  • Describe clinical outcomes of BioFlo PICC technology.
  • Describe accuracy rates of ECG placement technology compared to x-ray interpretation.


Supported by:

1277 Views